Expression of Autotaxin and Acylglycerol kinase in prostate cancer: Association with cancer development and progression

被引:55
|
作者
Nouh, Mohammed Ahmed Abdel Muneem [1 ,4 ]
Wu, Xiu-Xian [1 ]
Okazoe, Homare [1 ]
Tsunemori, Hiroyuki [1 ]
Haba, Reiji [2 ]
Abou-Zeid, Abdel Muneem Mohammed [4 ]
Saleem, Mohammed Diaa [4 ]
Inui, Masashi [1 ]
Sugimoto, Mikio [1 ]
Aoki, Junken [3 ]
Kakehi, Yoshiyuki [1 ]
机构
[1] Kagawa Univ, Fac Med, Dept Urol, Miki, Kagawa, Japan
[2] Kagawa Univ, Fac Med, Dept Pathol, Miki, Kagawa, Japan
[3] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Dept Mol & Cellular Biol, Sendai, Miyagi 980, Japan
[4] Sohag Univ, Sohag Fac Med, Dept Urol, Sohag, Egypt
关键词
LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; LPA; ACTIVATION; RECEPTORS; MOTILITY; PROTEIN; CELLS; MOLECULES; MARKER;
D O I
10.1111/j.1349-7006.2009.01234.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lysophosphatidic acid (LPA) may enhance diverse biologic activities in prostate cancer. This study was conducted to analyze expression levels of LPA-producing enzymes, autotaxin (ATX) and acylglycerol kinase (AGK), in prostate cancer with relevance to clinicopathological parameters. Real-time RT-PCR and western blotting were performed for ATX and AGK in non-neoplastic prostate cells (PrECs and PrSCs) and prostate cancer cell-lines (DU-145, PC-3, LNCaP, and AILNCaP). Immunohistochemical analyses were conducted in tissue specimens of 132 localized prostate cancer patients who underwent radical prostatectomy between 2001 and 2007 (median observation period, 22 months). Both enzymes were negatively expressed in PrECs and PrSCs at mRNA and protein levels. ATX expression was higher than AGK in AILNCaP, DU-145, and PC-3 cell-lines, while AGK was mainly expressed in LNCaP cells. Immunohistochemically, ATX and AGK expressions were negative in non-neoplastic epithelia, while both were weakly expressed in the majority of high-grade intra-epithelial neoplasia (HG-PIN). In cancer foci, ATX and AGK expressions were strong in 49% and 62%, weak in 40% and 32%, and negative in 11% and 6%, respectively. Expressions of both enzymes were significantly correlated with primary Gleason grade of cancer foci (P < 0.0001) and capsular invasion (P = 0.03 and 0.003 respectively). ATX expression was significantly correlated with probability of prostate specific antigen (PSA)-failure after surgery (P < 0.0001). In conclusion, LPA-producing enzymes (ATX and AGK) were frequently expressed in prostate cancer cells and precancerous HG-PIN. In particular, high expression levels of ATX were associated with both malignant potentials and poor outcomes. (Cancer Sci 2009; 100: 1631-1638).
引用
收藏
页码:1631 / 1638
页数:8
相关论文
共 50 条
  • [1] ELEVATED EXPRESSION OF LYSOPHOSPHOLIPASE D (AUTOTAXIN) AND ACYLGLYCEROL KINASE IN ONCOGENESIS AND PROGRESSION OF PROSTATE CANCER
    Nouh, Mohammed
    Kakehi, Yoshiyuki
    Wu, Xiuxian
    Tsunemori, Hiroyuki
    Sugimoto, Mikio
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 394 - 395
  • [2] Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes
    Abu El-Asrar, Ahmed M.
    Missotten, Luc
    Geboes, Karel
    [J]. ACTA OPHTHALMOLOGICA, 2012, 90 (02) : e84 - e89
  • [3] Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy
    Ahmed M. Abu El-Asrar
    Ghulam Mohammad
    Mohd Imtiaz Nawaz
    Mohammed Miraj Siddiquei
    Dustan Kangave
    Ghislain Opdenakker
    [J]. Acta Diabetologica, 2013, 50 : 363 - 371
  • [4] Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy
    Abu El-Asrar, Ahmed M.
    Mohammad, Ghulam
    Nawaz, Mohd Imtiaz
    Siddiquei, Mohammed Miraj
    Kangave, Dustan
    Opdenakker, Ghislain
    [J]. ACTA DIABETOLOGICA, 2013, 50 (03) : 363 - 371
  • [5] The Expression of Ubiquitous Mitochondrial Creatine Kinase Is Downregulated as Prostate Cancer Progression
    Amamoto, Rie
    Uchiumi, Takeshi
    Yagi, Mikako
    Monji, Keisuke
    Song, YooHyun
    Oda, Yoshinao
    Shiota, Masaki
    Yokomizo, Akira
    Naito, Seiji
    Kang, Dongchon
    [J]. JOURNAL OF CANCER, 2016, 7 (01): : 50 - 59
  • [6] Nemo-like kinase expression is altered during prostate cancer progression
    Brown, Lisha G.
    Pittsi, Tiffany E. M.
    Zhang, Xiaotun
    Vessella, Robert L.
    Corey, Eva
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase
    Rawat, Chitra
    Ben-Salem, Salma
    Singh, Nidhi
    Chauhan, Gaurav
    Rabljenovic, Anja
    Vaghela, Vishwa
    Venkadakrishnan, Varadha Balaji
    Macdonald, Jonathan D.
    Dahiya, Ujjwal R.
    Ghanem, Yara
    Bachour, Salam
    Su, Yixue
    Depriest, Adam D.
    Lee, Sanghee
    Muldong, Michelle
    Kim, Hyun-Tae
    Kumari, Sangeeta
    Valenzuela, Malyn May
    Zhang, Dingxiao
    Hu, Qiang
    Cortes Gomez, Eduardo
    Dehm, Scott M.
    Zoubeidi, Amina
    Jamieson, Christina A. M.
    Nicolas, Marlo
    Mckenney, Jesse
    Willard, Belinda
    Klein, Eric A.
    Magi-Galluzzi, Cristina
    Stauffer, Shaun R.
    Liu, Song
    Heemers, Hannelore V.
    [J]. CANCER RESEARCH, 2023, 83 (24) : 4142 - 4160
  • [8] Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression
    Treacy, Patrick-Julien
    Martini, Alberto
    Falagario, Ugo Giovanni
    Ratnani, Parita
    Wajswol, Ethan
    Beksac, Alp Tuna
    Wiklund, Peter
    Nair, Sujit
    Kyprianou, Natasha
    Durand, Matthieu
    Tewari, Ashutosh K.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [9] Fibromodulin expression in human prostate cancer tissue: Implications for prostate cancer progression
    Padron, Estebana Ines Benedetti
    De Marzo, Angelo
    Del Valle, Javier Baena
    Geliebter, Jan
    Reyes, Niradiz
    [J]. CANCER RESEARCH, 2017, 77
  • [10] MET expression during prostate cancer progression
    Verhoef, Esther I.
    Kolijn, Kimberley
    De Herdt, Maria J.
    van der Steen, Berdine
    Hoogland, A. Marije
    Sleddens, Hein F. B. M.
    Looijenga, Leendert H. J.
    van Leenders, Geert J. L. H.
    [J]. ONCOTARGET, 2016, 7 (21) : 31029 - 31036